publication date: Dec. 11, 2020

Drugs & Targets

FDA issues a guidance on quality standards of the Mammography Quality Standards Act during COVID-19

FDA is issuing a guidance on FDA’s enforcement policy regarding certain quality standards requirements under the Mammography Quality Standards Act of 1992.

The guidance is to provide general considerations to facilities that may have temporarily ceased performing mammography or that may be continuing to perform mammography while facing difficulty in complying with certain quality standards requirements during the public health emergency.

The MQSA is part of United States Code Title 42 – Public Health and Welfare, and is implemented in FDA’s regulations at 21 CFR part 900.

This policy is intended to remain in effect only for the duration of the public health emergency related to COVID-19 declared by the Secretary of Health and Human Services on Jan. 31, 2020, effective Jan. 27, 2020, including any renewals made by the HHS Secretary in accordance with section 319(a)(2) of the Public Health Service Act (PHS Act) (42 U.S.C. 247d(a)(2)).

This guidance is being implemented without prior public comment because FDA has determined that prior public participation for this guidance is not feasible or appropriate.

This guidance document is being implemented immediately, but it remains subject to comment in accordance with FDA’s good guidance practices.

 

Amgen and McKesson collaborate to advance cancer innovation in communities

McKesson and Amgen signed a strategic agreement to improve cancer care in community oncology settings.

Today, one in five cancer patients receives an Amgen medicine, while McKesson reaches 20% of U.S. cancer patients. This multi-year agreement will focus on reducing gaps in care by … Continue reading FDA issues a guidance on quality standards of the Mammography Quality Standards Act during COVID-19

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.